Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics
Takaaki Akaike,Tomoaki Ida,Fan-Yan Wei,Motohiro Nishida,Yoshito Kumagai,Md. Morshedul Alam,Hideshi Ihara,Tomohiro Sawa,Tetsuro Matsunaga,Shingo Kasamatsu,Akiyuki Nishimura,Masanobu Morita,Kazuhito Tomizawa,Akira Nishimura,Satoshi Watanabe,Kenji Inaba,Hiroshi Shima,Nobuhiro Tanuma,Minkyung Jung,Shigemoto Fujii,Yasuo Watanabe,Masaki Ohmuraya,Péter Nagy,Martin Feelisch,Jon M. Fukuto,Hozumi Motohashi
DOI: https://doi.org/10.1038/s41467-017-01311-y
IF: 16.6
2017-10-27
Nature Communications
Abstract:Cysteine hydropersulfide (CysSSH) occurs in abundant quantities in various organisms, yet little is known about its biosynthesis and physiological functions. Extensive persulfide formation is apparent in cysteine-containing proteins in Escherichia coli and mammalian cells and is believed to result from post-translational processes involving hydrogen sulfide-related chemistry. Here we demonstrate effective CysSSH synthesis from the substrate l-cysteine, a reaction catalyzed by prokaryotic and mammalian cysteinyl-tRNA synthetases (CARSs). Targeted disruption of the genes encoding mitochondrial CARSs in mice and human cells shows that CARSs have a crucial role in endogenous CysSSH production and suggests that these enzymes serve as the principal cysteine persulfide synthases in vivo. CARSs also catalyze co-translational cysteine polysulfidation and are involved in the regulation of mitochondrial biogenesis and bioenergetics. Investigating CARS-dependent persulfide production may thus clarify aberrant redox signaling in physiological and pathophysiological conditions, and suggest therapeutic targets based on oxidative stress and mitochondrial dysfunction.
multidisciplinary sciences